Concert Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference.LEXINGTON, Mass. -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Third Annual JMP JMP Jump JMP Java Memory Profiler JMP Joint Manpower Program JMP Joint Management Plan JMP Joint Marketing Program JMP JCL Manipulation Program JMP Joint Mission Planning (US DoD) JMP Joint Military Program Securities Healthcare Focus Conference, being held at the Le Parker Meridien in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday, October 6, 2008 at 4:00 p.m. (ET). About Concert Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company dedicated to creating medically and commercially important new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium deuterium (d  tēr`ēəm), isotope of hydrogen with mass no. 2. The deuterium nucleus, called a deuteron, contains one proton and one neutron. . Concert applies its innovative
platform to create highly differentiated compounds based on
well-understood biological targets and drug molecules, yielding a rich
pipeline of new chemical entities (NCEs). Concert leverages decades of
pharmaceutical experience to create drug candidates with potential for
best-in-class efficacy and safety, while reducing R&D risk, time,
and expense. The Company has over 100 patent applications for new drug
candidates addressing a broad range of therapeutic areas, including
vasomotor vasomotor /vaso·mo·tor/ (-mo´tor)1. affecting the caliber of blood vessels. 2. a vasomotor agent or nerve. va·so·mo·tor adj. symptoms, HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and fibrotic diseases, among others. Since its inception in 2006, Concert has raised more than $96 million and has been financed by leading venture capitalists Venture Capitalist An investor who provides capital to either start-up ventures or support small companies who wish to expand but do not have access to public funding. Notes: Venture capitalists usually expect higher returns for the additional risks taken. and institutional investors. A complete listing of Concert's shareholders and additional corporate information is available online at http://www.concertpharma.com. CoNCERT and CoNCERT Pharmaceuticals are trademarks of Concert Pharmaceuticals, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion